[ad_1]
Harry Pearson
Nice. Howdy everybody. Thanks for becoming a member of us this afternoon. My identify is Harry Pearson. I am with JPMorgan’s well being care funding banking workforce. It is my pleasure to be introducing Jim Clemmer, CEO of AngioDynamics; and Stephen Trowbridge, CFO. We’ll have a presentation adopted by a little bit time for Q&A. Take it away, Jim.
James Clemmer
CEO, President & Director
Thanks, Harry, and thanks for JPMorgan for an ideal convention once more. Thanks for becoming a member of us at this time. Earlier than I start, let me remind you to have a look at our forward-looking statements, remind you that we will offer you some ideas, concepts, plans and projections at this time. We will not assure you that each one these will come true. However do your good work as buyers, do your due diligence and make your finest selections.
So AngioDynamics is an organization that has gone via a change over the previous 5 years or so. We began off as an interventional radiology primarily based firm in upstate New York and constructed a powerful legacy serving that group. They obtained to know us effectively. we serve them effectively. However over time, our portfolio wanted to be refreshed. So myself and my colleagues took a glance about 6 years in the past of the place we must be, the place we should not be and actually tips on how to change the corporate via a extra vibrant scientific-based portfolio that compete in bigger, extra addressable markets.
So over the previous 5 years, the left aspect of the slide reveals you what we have finished, actually targeted on refreshing that portfolio. We did 3 divestitures to exit markets or
[ad_2]
